Lnc2Cancer

Experimentally Supported Human LncRNA and Cancer Associations Database

LncRNA centric

Cancer centric

Advanced search

Drug resistant

Circulating

Prognosis

Detail


   LncRNA Name FAM83H-AS1
   Synonyms FAM83H-AS1, onco-lncRNA-3
   Region NA    Sequence
   Ensembl NA
   RefSeq NR_033849
   Circulating
   Drug-resisitant
   Prognostic
   MiRNA
   Variant
   TF
   Methylation
   Cancer Name glioma
   ICD-0-3  M9380/3
   Methods qPCR, RIP, Western blot etc.
   Sample glioma tissues, cell line (U87 and U251)
   Expression Pattern up-regulated
   Function Description

FAM83H-AS1 was upregulated in glioma tissues and cell lines and high level of FAM83H-AS1 was associated with poor prognosis of glioma. Loss-of-function assays demonstrated that silenced FAM83H-AS1 obviously suppressed cell proliferation via regulating the cell-cycle distribution and cell apoptosis rate, and mechanistic experiments revealed that FAM83H-AS1 could epidemically silence CDKN1A expression through recruiting EZH2 to the promoter of CDKN1A, thereby influencing the cell cycle and proliferation. Moreover, the the Kaplanâ??Meier method (log-rank test) was used to analyze the correlation between FAM83HAS1 expression and overall survival of all patients and we found that high level of FAM83Hâ??AS1 was associated with poor prognosis ( p < 0.001, log-rank test).

   Pubmed ID 29870057
   Year 2018
   Title Long noncoding RNA FAM83H-AS1 exerts an oncogenic role in glioma through epigenetically silencing CDKN1A (p21).
   External Links
   Links for  FAM83H-AS1 GenBank       HGNC       lncrnadb       Noncode
   Links for  glioma Omim       Cosmic

CopyRight © College of Bioinformatics Science and Technology, Harbin Medical University, China.